Rephonic
Artwork for IJGC conversations

IJGC conversations

ijgcgroup
Ovarian Cancer
Endometrial Cancer
Lymphadenectomy
Neoadjuvant Chemotherapy
Circulating Tumor DNA
Sentinel Lymph Node Biopsy
Cervical Cancer
Immunotherapy
Low-Grade Serous Ovarian Cancer
Sentinel Lymph Node Mapping
National Cancer Database
Uterine Leiomyosarcoma
PARP Inhibitors
Oral Mucositis
Pembrolizumab
Gynecologic Oncology
Cancer In Pregnancy
Glp-1 Receptor Agonists
Checkpoint Inhibitors In Endometrial Cancer
Antibody Drug Conjugates (adcs) Gynecologic Cancers

The International Journal of Gynecological Cancer (IJGC) conversations is a podcast that brings you the latest insights into gynecologic malignancies. Tune in to engaging conversations with leading experts as they explore innovative and timely topics shaping the field. Hosted by the Editor-in-Chief Dr. Pedro Ramirez and special guests, each episode offers a dynamic and educational experience desig... more

PublishesWeeklyEpisodes93Founded2 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for IJGC conversations

Latest Episodes

In this IJGC podcast, Pedro Ramirez discusses Hormone replacement therapy in gynecologic cancer survivors with Blanca Gil-Ibáñez.

Dr. Blanca Gil-Ibáñez is a gynecologic oncologist at Hospital Universitario 12 de Octubre in Madrid, Spain. She was the... more

YouTube

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Charlotte LeJeune and Frédéric Amant to discuss ICG-Guided SLN Mapping in Cervical Cancer in Pregnancy.

Dr. Charlotte LeJeune is a clinical fellow in High-Risk ... more

YouTube

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Gabriel Levin to discuss Decline of Trachelectomy in Early Cervical Cancer.

Dr. Gabriel Levin is a gynecologic oncologist and clinical researcher at Bar-Ilan Uni... more

YouTube

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Alice Bergamini and Michael Seckl to discuss Management of Adult Ovarian Germ Cell Tumors.

Dr. Alice Bergamini is a gynecologist at the Gynecology and Obstetric... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Listen to Gynecologic Oncology
Listen to Gynecologic OncologyGynecologic Oncology
SGO on the GO
SGO on the GOThe Society of Gynecologic Oncology
Ready, Set, GYO!
Ready, Set, GYO!Ready, Set, GYO: An educational gynecologic oncology podcast
NEJM This Week
NEJM This WeekNEJM Group

Recent Guests

Blanca Gil-Ibáñez
Gynecologic oncologist at Hospital Universitario 12 de Octubre with research interests in cervical cancer, survivorship and sexual health
Hospital Universitario 12 de Octubre
Episode: Hormone replacement therapy in gynecologic cancer survivors
Charlotte LeJeune
Clinical fellow in High-Risk Obstetrics at University Hospitals Leuven researching cancer during pregnancy
University Hospitals Leuven
Episode: ICG-Guided SLN Mapping in Cervical Cancer in Pregnancy
Frédéric Amant
Gynecologic oncologist and professor who founded the International Network on Cancer, Infertility and Pregnancy
KU Leuven
Episode: ICG-Guided SLN Mapping in Cervical Cancer in Pregnancy
Gabriel Levin
Gynecologic oncologist and clinical researcher
McGill University Health Center
Episode: Decline of Trachelectomy in Early Cervical Cancer
Alice Bergamini
Gynecologist and university researcher focused on gynecological oncology and rare cancers
Vita-Salute San Raffaele University
Episode: Management of Adult Ovarian Germ Cell Tumors
Michael Seckl
Professor of Molecular Oncology and director of the National Trophoblastic Disease and MOGCT Centre
Imperial College London
Episode: Management of Adult Ovarian Germ Cell Tumors
René Pareja
Editor-in-Chief, International Journal of Gynecological Cancer
International Journal of Gynecological Cancer
Episode: Gynecologic Oncology Practice in Low & Middle Resource Settings
Quetalo Russo
Guest expert from Humanitas University and Hospital
Humanitas University; Humanitas San Pio Dieci Hospital
Episode: ROSELLA Trial: Overall Survival Outcomes
Emese Zsiros
Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center
Roswell Park Comprehensive Cancer Center
Episode: KEYNOTE-B96: Pembrolizumab and Weekly Paclitaxel in Ovarian Cancer

Host

Pedro Ramirez
Editor-in-Chief of IJGC, host of IJGC Conversations

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

ICG-Guided SLN Mapping in Cervical Cancer in Pregnancy
Q: What were the main findings and takeaways from your study?
LeJeune reports that the retrospective series included 11 pregnant patients with cervical cancer from seven European centers. At least one sentinel node was identified in 10 patients and bilateral mapping was achieved in eight. One patient had positive nodes and later recurred. The authors describe mapping as feasible in carefully selected patients, while cautioning that the small series cannot establish safety or diagnostic accuracy.
ICG-Guided SLN Mapping in Cervical Cancer in Pregnancy
Q: Can you briefly walk us through the 2025 ESGO guidelines' framework for cervical cancer during pregnancy and explain the rationale for an individualized approach?
Amant says decisions depend on gestational age, tumor features, surgical options and what the patient would do with lymph node results. Chemotherapy is generally avoided in the first trimester, while cervical surgery and lymph node access have distinct pregnancy-related risks. The guidance distinguishes patients before and after 24 weeks, while emphasizing specialist care and shared decision-making.
Hormone replacement therapy in gynecologic cancer survivors
Q: Are we being too quick to declare hormone replacement therapy safe in gynecologic cancer survivors when much of the evidence comes from observational studies and underpowered trials?
Gil-Ibáñez says treatment should follow the strength of available evidence: use it where evidence supports safety, including cervical cancer, early-stage low-risk endometrial cancer and most high-grade epithelial ovarian cancers. When evidence is limited, clinicians should individualize decisions and discuss uncertainty with patients while continuing to generate better evidence.
Hormone replacement therapy in gynecologic cancer survivors
Q: What would you consider absolute contraindications to allow for hormone replacement therapy in gynecologic cancer survivors, and in which situations might individualized decision making be appropriate?
Gil-Ibáñez recommends avoiding systemic hormone therapy for clearly hormone-sensitive tumors, including endometrial stromal sarcoma, low-grade serous ovarian cancer and granulosa cell tumors. For advanced or high-risk endometrial cancer, she says evidence is limited, so clinicians should weigh tumor biology, symptoms, estrogen-deprivation effects and other health risks. Low-dose vaginal estrogen may be an option for genitourinary symptoms because systemic absorption is minimal.
Management of Adult Ovarian Germ Cell Tumors
Q: What are your criteria for determining the optimal sequencing of chemotherapy and surgery for bulky advanced stage presentations?
Seckl says there are no fixed criteria, but inoperable stage 4 or very advanced stage 3 disease generally calls for neoadjuvant chemotherapy so surgery does not delay treatment. A biopsy may be needed when markers are negative and the diagnosis is uncertain.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About IJGC conversations

What is IJGC conversations about and what kind of topics does it cover?

The episodes feature in-depth conversations with leading gynecologic oncologists, researchers, and clinical trialists who dissect emerging practices, trial designs, and biomarker-driven strategies in gynecologic cancers. Common threads include surgical innovation (robotic and sentinel lymph node techniques), targeted and immuno-oncology approaches, and the evolving role of molecular profiling in guiding adjuvant and de-escalation decisions. Guests frequently debate real-world data versus randomized evidence, highlight practical challenges in trial design and implementation, and translate complex results into actionable takeaways for clinicians. A notable strength is the breadth of perspectives from major cancer centers worldwide, with a str... more

Where can I find podcast stats for IJGC conversations?

Rephonic provides a wide range of podcast stats for IJGC conversations. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to IJGC conversations and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does IJGC conversations get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for IJGC conversations, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for IJGC conversations?

Rephonic provides comprehensive predictive audience data for IJGC conversations, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does IJGC conversations have?

To see how many followers or subscribers IJGC conversations has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to IJGC conversations?

These podcasts share a similar audience with IJGC conversations:

1. Listen to Gynecologic Oncology
2. Gynecologic Oncology Update
3. SGO on the GO
4. Ready, Set, GYO!
5. NEJM This Week

How many episodes of IJGC conversations are there?

IJGC conversations launched 2 years ago and published 93 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact IJGC conversations?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for IJGC conversations?

Rephonic pulls ratings and reviews for IJGC conversations from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for IJGC conversations?

Rephonic provides full transcripts for episodes of IJGC conversations. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on IJGC conversations?

Recent guests on IJGC conversations include:

1. Blanca Gil-Ibáñez
2. Charlotte LeJeune
3. Frédéric Amant
4. Gabriel Levin
5. Alice Bergamini
6. Michael Seckl
7. René Pareja
8. Quetalo Russo

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days